Patents by Inventor Robert Owen Sayers

Robert Owen Sayers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-myostatin antibodies
    Patent number: 8063188
    Abstract: Monoclonal anti-myostatin antibodies that preferentially bind myostatin over GDF-11, have strong binding affinity to myostatin and are resistant to chemical degradation. The antibodies of the invention are useful for increasing muscle mass, increasing bone density, or for the treatment or prevention of various disorders in mammalian and avian species.
    Type: Grant
    Filed: August 23, 2007
    Date of Patent: November 22, 2011
    Assignee: Eli Lilly and Company
    Inventors: Robert Owen Sayers, Lihua Huang
  • ANTI-MYOSTATIN ANTIBODIES
    Publication number: 20100166764
    Abstract: Monoclonal anti-myostatin antibodies that preferentially bind myostatin over GDF-11, have strong binding affinity to myostatin and are resistant to chemical degradation. The antibodies of the invention are useful for increasing muscle mass, increasing bone density, or for the treatment or prevention of various disorders in mammalian and avian species.
    Type: Application
    Filed: August 23, 2007
    Publication date: July 1, 2010
    Inventors: Robert Owen Sayers, Lihua Huang